Millennium Management’s Acer Therapeutics Inc ACER Stock Holding History

Millennium Management’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,451	Closed	-$33K	–	7414
2021 Q2	$33K	Buy	+11,451	New	+$33K	﹤0.01%	6404
2019 Q4	–	Sell	-15,304	Closed	-$48K	–	4737
2019 Q3	$48K	Buy	+15,304	New	+$44.9K	﹤0.01%	4048
2019 Q2	–	Sell	-59,892	Closed	-$1.46M	–	4595
2019 Q1	$1.46M	Buy	+59,892	New	+$1.41M	﹤0.01%	2629
2017 Q1	–	Sell	-1,520	Closed	-$15K	–	3936
2016 Q4	$15K	Buy	+1,520	New	+$26.6K	﹤0.01%	3280

Other funds holding ACER

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Millennium Management's ACER Position: Q3 2021 in Review

Millennium Management sold out of Acer Therapeutics Inc (ACER) in Q3 2021, closing a stake of 11,451 shares — an estimated $33K sold.

Millennium Management first reported a position in ACER in Q4 2016 and held it in 4 quarters. The position peaked at $1.46M in Q1 2019. 25 funds tracked by Wall St. Rank hold ACER as of Q3 2021.

Millennium Management reported no remaining Acer Therapeutics Inc position as of Q3 2021 after selling out during the quarter.
Millennium Management sold 11,451 Acer Therapeutics Inc shares in Q3 2021, an estimated $33K.
Millennium Management first reported a position in Acer Therapeutics Inc in Q4 2016 and held it in 4 quarters.
Millennium Management's Acer Therapeutics Inc position peaked at $1.46M in Q1 2019.
25 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2021.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.